Traduction de «Completion ratio » (Anglais → Français) :

answer seizure ratio | completion ratio | efficiency rate

acceptance rate | completeness | hit rate | recall factor | recall ratio | sensitivity

Modifiers The following fourth-character subdivisions are for use with categories O03-O06: Incomplete abortion includes retained products of conception following abortion. Code Title .0 Incomplete, complicated by genital tract and pelvic infection With conditions in O08.0 .1 Incomplete, complicated by delayed or excessive haemorrhage With conditions in O08.1 .2 Incomplete, complicated by embolism With conditions in O08.2 .3 Incomplete, with other and unspecified complications With conditions in O08.3-O08.9 .4 Incomplete, without complication .5 Complete or unspecified, complicated by genital tract and pelvic infection With conditions in ...[+++]O08.0 .6 Complete or unspecified, complicated by delayed or excessive haemorrhage With conditions in O08.1 .7 Complete or unspecified, complicated by embolism With conditions in O08.2 .8 Complete or unspecified, with other and unspecified complications With conditions in O08.3-O08.9 .9 Complete or unspecified, without complication | With conditions in O08.0 | With conditions in O08.1 | With conditions in O08.2 | With conditions in O08.3-O08.9 | With conditions in O08.0 | With conditions in O08.1 | With conditions in O08.2 | With conditions in O08.3-O08.9

recall ratio [ recall factor | recall | hit rate | sensitivity | completeness ]

waist-to-hip ratio | WHR | waist to hip ratio | waist hip ratio | waist-hip ratio | waist/hip ratio | waist/hip circumference ratio | waist hip circumference ratio | waist to hip girth ratio

debt-equity ratio [ debt/equity ratio | debt-to-equity ratio | debt ratio | owe-to-own ratio | debt to total assets ratio | debt to total assets ]

debt ratio | debt-to-GDP ratio | general government debt ratio | government debt ratio | public debt ratio

Definition: A disorder characterized by a partial or complete loss of the normal integration between memories of the past, awareness of identity and immediate sensations, and control of bodily movements (see F44.-), but arising as a consequence of an organic disorder.

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

Where, in accordance with the second subparagraph of Article 13(1) of Regulation (EU) No 575/2013, institutions have the obligation to disclose any information on the leverage ratio at sub-consolidated level and in order to keep the administrative burden proportionate to the objectives of the rules on leverage ratio disclosure, rules on the leverage ratio disclosure should not require those institutions to complete and publish the template entitled ‘LRSpl’ at sub-consolidated level.

1. Where, in accordance with Article 499(2) of Regulation (EU) No 575/2013, institutions change their choice of leverage ratio to be disclosed, they shall disclose the reconciliation of the information on all leverage ratios disclosed up to the moment of that change by completing and publishing the templates entitled ‘LRSum’, ‘LRCom’, ‘LRSpl’ and ‘LRQua’ set out in Annex I for each of the reference dates corresponding to the leverage ratios disclosed up to the moment of the change.

Institutions shall disclose the description of the processes used to manage the risk of excessive leverage and of the factors that have had an impact on the leverage ratio during the period to which the disclosed leverage ratio refers, as referred to in points (d) and (e) of Article 451(1) of Regulation (EU) No 575/2013, by completing and publishing the template entitled ‘LRQua’ set out in Annex I in accordance with the instructions set out in Annex II.

6. In the situations described in paragraphs 1 and 4 above, the competent institution shall determine the amount of the benefit as if all the creditable periods had been completed under its own legislation; for the purposes of the payment of the benefit, it shall calculate the part for which it is liable on the basis of the ratio between the creditable periods completed exclusively in Chile and the total creditable periods completed in both Parties.